|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Gilead Sciences (NASDAQ: GILD) through any online brokerage.
The latest price target for Gilead Sciences (NASDAQ: GILD) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 84.00 expecting GILD to rise to within 12 months (a possible 24.02% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Gilead Sciences (NASDAQ: GILD) is $67.73 last updated Tue Oct 26 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Gilead Sciences. The last dividend paid out to investors was $0.04 on September 14, 2021.
Gilead Sciences’s $Q3 earnings are confirmed for after-market on $October 28, 2021.
There is no upcoming split for Gilead Sciences.
Gilead Sciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.